20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with indapamide in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (indapamide) | Trials (indapamide) | Recent Studies (post-2010) (indapamide) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 1,089 | 350 | 264 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | indapamide (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.918 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Cheng, J; Lin, F; Ma, F; Wang, DW; Wang, Y; Zeldin, DC | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and indapamide
| Article | Year |
|---|---|
Indapamide lowers blood pressure by increasing production of epoxyeicosatrienoic acids in the kidney.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Epoxide Hydrolases; Hydrochlorothiazide; Hydroxyeicosatetraenoic Acids; Indapamide; Inflammation; Kidney; Male; Mitogen-Activated Protein Kinase 1; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride Symporter Inhibitors; Transforming Growth Factor beta1 | 2013 |